Q3 2015 Holdings
Filed 2015-11-13 | 160 holdings | $289.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xencor, Inc.(XNCR) | Common | 98401F105 | $245 | 20,000 | 0.0% |
| MacroGenics, Inc.(MGNX) | Common | 556099109 | $273 | 12,743 | 0.0% |
| Kite Pharma, Inc. | Common | 49803L109 | $351 | 6,300 | 0.0% |
| Zafgen, Inc. | Common | 98885E103 | $425 | 13,307 | 0.0% |
| Cidara Therapeutics, Inc. | Common | 171757107 | $636 | 50,000 | 0.0% |
| Cynapsus Therapeutics, Inc. | Common | 23257Y859 | $799 | 49,322 | 0.0% |
| Galapagos NV(GLPG) | Sponsored ADR | 36315X101 | $814 | 20,000 | 0.0% |
| Trillium Therapeutics Inc. | Common | 89620X506 | $847 | 65,000 | 0.0% |
| Bellicum Pharmaceutical, Inc. | Common | 079481107 | $872 | 60,000 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $895 | 500,000 | 0.0% |
| Abaxis, Inc. | Common | 002567105 | $988 | 22,466 | 0.0% |
| BioDelivery Sciences International, Inc.(BDSIUSD) | Common | 09060J106 | $1.4K | 250,000 | 0.0% |
| Affimed NV | Common | N01045108 | $1.4K | 228,083 | 0.0% |
| Tetraphase Pharmaceuticals Inc. | Common | 88165N105 | $1.4K | $192,322 | 0.0% |
| GenMark Diagnostics, Inc.(GNMK) | Common | 372309104 | $1.7K | 215,149 | 0.0% |
| Chimerix Inc.(CMRXEUR) | Common | 16934W106 | $1.8K | 47,800 | 0.0% |
| UniQure NV(QURE)Call | Common | N90064101 | $2.1K | 102,800 | 0.0% |
| UniQure NV(QURE) | Common | N90064101 | $2.1K | 102,800 | 0.0% |
| DBV Technologies S.A. | Sponsored ADR | 23306J101 | $2.3K | 65,600 | 0.0% |
| Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | $2.3K | $1,485,000 | 0.0% |
| Accelerate Diagnostics, Inc. | Common | 00430H102 | $2.3K | 144,625 | 0.0% |
| TetraLogic Pharmaceuticals Corporation | Note 8.00% 6/15/19 | 88165UAB5 | $2.4K | $4,500,000 | 0.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY)Call | Common | 02043Q107 | $2.4K | 29,500 | 0.0% |
| Esperion Therapeutics, Inc.(ESPR)Call | Common | 29664W105 | $2.4K | 102,800 | 0.0% |
| Esperion Therapeutics, Inc.(ESPR) | Common | 29664W105 | $2.4K | 102,800 | 0.0% |
| Momenta Pharmaceuticals, Inc.(MNTA) | Common | 60877T100 | $2.5K | 153,700 | 0.0% |
| Grifols SA(GRFS) | Sponsored ADR | 398438408 | $2.5K | 83,000 | 0.0% |
| The Medicines Company(MPT)Call | Common | 58463J304 | $2.7K | 70,300 | 0.0% |
| Care Capital Properties, Inc. | Common | 141624106 | $2.8K | 84,316 | 0.0% |
| Flex Pharma, Inc. | Common | 33938A105 | $2.8K | 232,600 | 0.0% |
| Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | $2.8K | 206,000 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN)Call | Common | 015351109 | $2.8K | 18,200 | 0.0% |
| Perrigo Company PLC(PRGO) | Common | G97822103 | $3.0K | 18,900 | 0.0% |
| Forward Pharma A/S | Sponsored ADR | 34986J105 | $3.1K | 132,447 | 0.0% |
| Trovagene, Inc. | Common | 897238309 | $3.1K | 550,000 | 0.0% |
| Horizon Pharma PlcCall | Common | G4617B105 | $3.2K | 162,900 | 0.0% |
| Horizon Pharma Plc | Common | G4617B105 | $3.2K | 162,900 | 0.0% |
| Wright Medical Group Inc. | Common | 98235T107 | $3.3K | 156,100 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $3.3K | 256,700 | 0.0% |
| Karyopharm Therapeutics Inc.(KPTIEUR)Call | Common | 48576U106 | $3.3K | 316,900 | 0.0% |
| Puma Biotechnology, Inc.(PBYI)Call | Common | 74587V107 | $3.4K | 45,400 | 0.0% |
| Sage Therapeutics, Inc.(SG7)Call | Common | 78667J108 | $3.5K | 82,800 | 0.0% |
| Celldex Therapeutics, Inc. | Common | 15117B103 | $3.6K | 338,400 | 0.0% |
| BioMarin Pharmaceutical Inc.(BMRN)Call | Common | 09061G101 | $3.7K | 35,500 | 0.0% |
| DepoMed Inc. | Common | 249908104 | $3.8K | 200,000 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | Common | 00448Q201 | $3.8K | 547,300 | 0.0% |
| GW Pharmaceuticals PlcCall | Common | 36197T103 | $3.8K | 41,400 | 0.0% |
| Lexicon Pharmaceuticals, Inc.(LXRX) | Common | 528872302 | $3.8K | 353,900 | 0.0% |
| Lexicon Pharmaceuticals, Inc.(LXRX)Call | Common | 528872302 | $3.8K | 353,900 | 0.0% |
| Inotek Pharmaceuticals Corp. | Common | 45780V102 | $4.0K | 425,000 | 0.0% |